TADALAFIL
NDC 13668-581, TADALAFIL, tablet, from Torrent Pharmaceuticals Limited.
- Product NDC
- 13668-581
- Status
- Listed
- Labeler
- Torrent Pharmaceuticals Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212062
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/13668-581 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TADALAFIL20 mg/1
Pharmacologic classes
Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 13668-581-30 | 13668058130 | 30 TABLET in 1 BOTTLE (13668-581-30) |
| 13668-581-60 | 13668058160 | 60 TABLET in 1 BOTTLE (13668-581-60) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/88132351-7fee-47ef-8007-ef2777543299NADAC price for package 13668058130
GET /v1/drugs/nadac/13668058130
Use it
Look up 13668-581 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/13668-581 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 13668-581. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.